Differential Predictors and Clinical Implications Associated With Long-Term Survivors in IDH Wildtype and Mutant Glioblastoma

Differential Predictors and Clinical Implications Associated With Long-Term Survivors in IDH Wildtype and Mutant Glioblastoma

BackgroundGlioblastoma (GBM) is the most aggressive intracranial tumor which can be divided into two subtypes based on status of isocitrate dehydrogenase (IDH). A small fraction of patients after receiving standard treatment can be long-term survivors (LTS). This study was designed to disclose the p...

Full description

Bibliographic Details
Main Authors: Haihui Jiang, Kefu Yu, Yong Cui, Xiaohui Ren, Mingxiao Li, Guobin Zhang, Chuanwei Yang, Xuzhe Zhao, Qinghui Zhu, Song Lin
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Oncology
Subjects:
glioblastoma
long-term survivor
IDH
precision medicine
treatment
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.632663/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.632663/full

Similar Items